Home
Deutsch
Advanced Search
Browse by ...
Publication overview
Contact persons
Help
DOI
 |
|
as soon as is submitted to ZB.
Current and future biomarkers for allergy and asthma.
In: Implement. Precis. Medicine in Best Practices of Chronic Airw. Diseases. 2018. 91-94
Clinical endotypes of airway diseases are undermining successful treatment of allergic diseases. Novel biomarkers were identified and are summarized, but really critical is the future strategy to combine several markers to generate powerful prediction algorithms. These should be strong enough to allow conclusions for individual patients. Biomarkers beyond the type-2 group may allow distinction of patients even in the temporary absence of triggering factors such as allergens. But also noninvasive sampling methods taking advantage of nasal secretions are promising and are summarized in this chapter.
Altmetric
Additional Metrics?
Edit extra informations
Login
Publication type
Article: Edited volume or book chapter
Keywords
Biomarkers ; Endotype ; Lung Samples ; Nasal Samples
Book Volume Title
Implement. Precis. Medicine in Best Practices of Chronic Airw. Diseases
Quellenangaben
Pages: 91-94
Non-patent literature
Publications
Institute(s)
Institute for Allergy Research (IAF)